-
Mashup Score: 0Blog — NephJC - 7 month(s) ago
The kidney cell architecture atlas infographic by Dr Jithu Kurian This week, we will discuss some groundbreaking work on elucidating the adaptive and maladaptive cellular transcription and gene activation of the kidney in healthy and diseased states. …
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 3The Kidney Cellular Architecture Atlas — NephJC - 8 month(s) ago
The kidney cell architecture atlas infographic by Dr Jithu Kurian
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 3Newsletter — NephJC - 8 month(s) ago
We send an e-mail once-a-week with a breakdown and summary of every article we discuss at #NephJC. If you are interested in getting this e-mail, sign up here.We promise to:Respect your privacyNever sell your e-maill addressNever send more than one e-mail a week
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Merchandise — NephJC - 8 month(s) ago
NephJC is a not-for-profit organization and recognized by the US IRS as a 503c. All money raised is spent on the #NephTwitter community. NephJC is governed by a 5 member board of directors. Joel Topf, presidentSwapnil Hiremath, vice presidentMatt Sparks, treasurerAnna BurgnerMichelle Rheault, secretaryFunds are used to support the The Kidney Week and KIDNEYcon Tweet-ups. Money is used to help…
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 6Breaking the discord between patients’ goals and traditional trial outcomes: the SWIFT trial — NephJC - 10 month(s) ago
In this edition of NephTrials, we will discuss the importance of PROS, PROMS, PREMS, anchoring the discussion to the SWIFT trial
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 8Breaking the discord between patients’ goals and traditional trial outcomes: the SWIFT trial — NephJC - 10 month(s) ago
In this edition of NephTrials, we will discuss the importance of PROS, PROMS, PREMS, anchoring the discussion to the SWIFT trial
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 1Freely Filtered 059: Furosemide v Torsemide — NephJC - 10 month(s) ago
Freely Filtered 059: Another dogma shredding trial about diuretics, this time torsemide goes up against king furosemide and its ability to prevent rehospitalization CV events.
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 4NephJC 2023 Pledge Drive — NephJC - 10 month(s) ago
Help keep NephJC a vital, original, and unbiased source of medical education.
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 3HDF vs HD: Need for CONVINCE-ing Evidence — NephJC - 10 month(s) ago
This week, we will discuss CONVINCE, a randomized controlled trial, about the long-lasting battle between hemodialysis and hemodiafiltration. Will it convince the unconvinced, or will it diffuse even more uncertainty into community?
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 4The CONVINCE Visual Abstract — NephJC - 10 month(s) ago
Flozinator Blog PodCast …
Source: NephJCCategories: Latest Headlines, NephrologyTweet
Join discussions in #NephJC! NephJC is a journal club held twice a month to cover exciting new advances in nephrology - from basic and translational science to clinical trials - it'll help keep you up to date on the latest and greatest in nephrology. https://t.co/OgNQQDLLVV